This scholarship page was last updated on 15 December 2022. Some details may have changed since then. Please check the Department of Health and Human Services National Institutes of Health website or the Department of Health and Human Services National Institutes of Health page for current opportunities.

Co-infection and Cancer (R21 Clinical Trial Not Allowed)

Department of Health and Human Services National Institutes of Health
Type

Research/project funding

Posted on:

Application Deadline:

Expired

Reference Number

PAR-23-056

The purpose of this Funding Opportunity Announcement (FOA) is to enhance mechanistic and epidemiologic investigations addressing the roles of co-infection and cancer to shed light on presently unestablished pathways in carcinogenesis that may inform prevention and treatment strategies for infection-related cancers. Co-infection is defined as the occurrence of infections by two or more infectious (pathogenic or non-pathogenic) agents either concurrently or sequentially and includes both acute and chronic infections by viruses, bacteria, parasites, and/or other microorganisms. Preference will be given to investigations of co-infections with known oncogenic agents (excluding human immunodeficiency virus [HIV]) and of co-infections that engender novel opportunities for prevention and treatment.
Categories: Education, Health.

More Information

Type

Research/Project Funding

Posted on:

Application Deadline:

Expired

Reference Number

PAR-23-056

United States